SPEAKER_04

I'm alive.

It's nice to have two of them.

Yes, exactly.

I'm alive.

But, you know, this early detection is important.

I mean, I was lucky that it hadn't metastasized yet.

It was called clear cell renal cell carcinoma.

But, you know, so...

surveying the body and these companies that are out there right now which do it, I think are really important.

Because even if you are young and you have no suspicion you're going to have cancer, having that baseline against which you can compare later changes is important.

Because I could do, for instance, a CT scan or an MRI of you, and I'd find lots of little anomalies.

And they're generally in the field called phantomas.

There are these objects that may be worrisome, but we won't know that they're worrisome.

And certainly, I could do a biopsy of them and poke a needle into your chest to pick out a piece of it.

But if I come back six months and it's changed, then maybe it's something we need to go after more seriously.

So getting those kinds of regular scans, I think, is probably one of the more important things that could be done, but not by a CT scan.

Yeah, but maybe, for instance, there'd be a way to treat someone with a drug ahead of time that would minimize the effect of the CT scan.

Right?

Because the CT scans are generally causing oxidative damage.

And so if you could provide a local antioxidant, and I'm not saying that something like this exists.